Skip to main content
logo
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.060
-0.120 (-3.77%)
At close: Oct 23, 2026, 4:00 PM EDT
3.090
+0.030 (0.98%)
Pre-market: Oct 26, 2026, 5:01 AM EDT

C4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3761852542782891,566
Market Cap Growth
77.41%-27.16%-8.73%-3.60%-81.55%9.83%
Enterprise Value
1334737104111,108
Last Close Price
3.061.913.605.655.9032.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.745.157.1413.429.2934.20
PB Ratio
1.520.721.181.131.004.02
P/TBV Ratio
1.520.721.181.131.004.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.791.301.035.020.3524.20

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.230.230.300.290.300.11
Net Debt / Equity Ratio
-0.98-0.92-0.93-0.86-0.86-1.05
Net Debt / EBITDA Ratio
2.452.311.751.541.965.07
Net Debt / FCF Ratio
2.852.393.081.942.244.63
Asset Turnover
0.110.100.100.050.070.10
Quick Ratio
5.297.605.496.216.236.15
Current Ratio
5.457.815.716.346.466.36
Return on Equity (ROE)
-48.14%-44.44%-45.58%-49.50%-37.76%-25.03%
Return on Assets (ROA)
-19.25%-18.43%-20.17%-21.53%-17.27%-11.32%
Return on Capital Employed (ROCE)
-32.50%-32.00%-38.50%-41.70%-33.50%-18.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-29.69%-56.72%-41.44%-47.58%-44.38%-5.36%
FCF Yield
-22.68%-53.64%-25.71%-38.98%-38.58%-5.64%
Buyback Yield / Dilution
-58.30%-19.49%-39.75%-1.59%-6.13%-304.93%
SEC Filings: 10-K · 10-Q